Simplex Trading, LLC Immunovant, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 48,191 shares of IMVT stock, worth $1.33 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

48,191

Previous 56,961 15.4%

Holding current value

$1.33 Million

Previous $1.5 Million 11.84%

% of portfolio

0.05%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$27.51 - $27.51 $241,262 - $241,262	-8,770 Reduced 15.4%	48,191 $1.33 Million
Q2 2024 Jul 25, 2024	BUY	$25.1 - $31.61 $802,497 - $1.01 Million	31,972 Added 127.94%	56,961 $1.5 Million
Q1 2024 Apr 25, 2024	SELL	$30.27 - $43.79 $1.59 Million - $2.3 Million	-52,493 Reduced 67.75%	24,989 $807,000
Q4 2023 Feb 02, 2024	SELL	$31.31 - $44.19 $1.49 Million - $2.11 Million	-47,730 Reduced 38.12%	77,482 $3.26 Million
Q3 2023 Nov 01, 2023	BUY	$18.55 - $39.96 $1.94 Million - $4.18 Million	104,706 Added 510.61%	125,212 $4.81 Million
Q2 2023 Aug 04, 2023	BUY	$14.2 - $23.75 $66,058 - $110,485	4,652 Added 29.34%	20,506 $388,000
Q1 2023 Apr 27, 2023	BUY	$15.27 - $19.72 $112,417 - $145,178	7,362 Added 86.69%	15,854 $245,000
Q4 2022 Feb 02, 2023	SELL	$6.59 - $17.75 $7,150 - $19,258	-1,085 Reduced 11.33%	8,492 $150,000
Q3 2022 Nov 04, 2022	BUY	$3.93 - $6.37 $37,421 - $60,655	9,522 Added 17312.73%	9,577 $53,000
Q2 2022 Aug 03, 2022	BUY	$3.38 - $5.65 $185 - $310	55 New	55 $0
Q1 2022 May 02, 2022	SELL	$5.06 - $8.77 $20,336 - $35,246	-4,019 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$7.33 - $9.32 $49,704 - $63,198	-6,781 Reduced 62.79%	4,019 $34,000
Q3 2021 Oct 28, 2021	BUY	$7.01 - $11.37 $44,134 - $71,585	6,296 Added 139.79%	10,800 $122,000
Q2 2021 Aug 12, 2021	BUY	$9.4 - $16.85 $42,337 - $75,892	4,504 New	4,504 $47,000

Others Institutions Holding IMVT

# of Institutions

212

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Immunovant, Inc. Transaction History